Integumen PLC's (LON:SKIN) Gerry Brandon speaks to Proactive's Andrew Scott after unveiling a new personalised coronavirus breath test, Microtox BT, and a complimentary digital health pass platform which he says has the potential to enable instant real-time testing for the virus. Brandon says from a regulatory perspective it's capable of being fast-tracked on a number of levels and has the potential to be available in 4-5 months.
Integumen PLC to seek fast-track approval for its new coronavirus breath test
Quick facts: DeepVerge plc
Price: 32.75 GBX
Market Cap: £37.19 m
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of DeepVerge plc named herein, including the promotion by the Company of DeepVerge plc in any Content on the Site, the Company receives from said...FOR OUR FULL DISCLAIMER CLICK HERE